Irvine, CA — September 8, 2025 — Leads & Copy — Klotho Neurosciences, Inc. (NASDAQ: KLTO) announced that CEO and Chairman Dr. Joseph Sinkule will attend the Inaugural Klotho Conference & Scientific Seminar, set for September 15-16, 2025, at the UC-Irvine Beal Applied Innovation Center.
The conference marks the first event focusing on the future of klotho-based therapies and diagnostics. Key scientific advisors and inventors, Dr. Miguel Chillon and Dr. Assumpcio Bosch, will present research on Klotho gene therapy in treating ALS, Alzheimer’s, and longevity.
Dr. Sinkule will be available for meetings with investors and potential partners during the conference.
Jeffrey LeBlanc, CFO, can be contacted at ir@klothoneuro.com.
Source: Klotho Neurosciences, Inc.
